Huiyu Wang

1.0k total citations
35 papers, 736 citations indexed

About

Huiyu Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Huiyu Wang has authored 35 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Huiyu Wang's work include Ferroptosis and cancer prognosis (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer-related molecular mechanisms research (4 papers). Huiyu Wang is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer-related molecular mechanisms research (4 papers). Huiyu Wang collaborates with scholars based in China, United States and New Zealand. Huiyu Wang's co-authors include Chaoying Liu, Jie Mei, Rui Xu, Baorui Liu, Guangli Yan, Xiuhong Wu, Xijun Wang, Yuan Li, Xinyu Shao and Shishuo Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Huiyu Wang

33 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiyu Wang China 15 451 178 113 94 83 35 736
Sau Har Lee Malaysia 13 314 0.7× 136 0.8× 123 1.1× 43 0.5× 45 0.5× 34 731
Lina Gao China 17 475 1.1× 288 1.6× 83 0.7× 42 0.4× 80 1.0× 35 939
Cristian Moldovan Romania 17 322 0.7× 179 1.0× 173 1.5× 91 1.0× 120 1.4× 53 854
Xinbin Gu United States 18 597 1.3× 324 1.8× 99 0.9× 39 0.4× 67 0.8× 45 957
Adrian Bogdan Țigu Romania 14 463 1.0× 242 1.4× 147 1.3× 42 0.4× 47 0.6× 68 912
Xiaomeng Tang China 18 392 0.9× 107 0.6× 90 0.8× 196 2.1× 54 0.7× 38 945
Wenhao Guo China 20 500 1.1× 246 1.4× 237 2.1× 89 0.9× 166 2.0× 30 1.0k
Jingbin� Huang China 14 361 0.8× 101 0.6× 70 0.6× 70 0.7× 45 0.5× 34 627
Yan Lin China 15 522 1.2× 193 1.1× 155 1.4× 49 0.5× 59 0.7× 44 779
Sian Chen China 11 519 1.2× 331 1.9× 104 0.9× 37 0.4× 77 0.9× 18 801

Countries citing papers authored by Huiyu Wang

Since Specialization
Citations

This map shows the geographic impact of Huiyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiyu Wang more than expected).

Fields of papers citing papers by Huiyu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiyu Wang. The network helps show where Huiyu Wang may publish in the future.

Co-authorship network of co-authors of Huiyu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Huiyu Wang. A scholar is included among the top collaborators of Huiyu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiyu Wang. Huiyu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Ziyu, et al.. (2024). Caloric restriction, Sirtuins, and cardiovascular diseases. Chinese Medical Journal. 137(8). 921–935. 9 indexed citations
2.
Wang, Huiyu, et al.. (2023). HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome. Heliyon. 9(10). e21056–e21056. 3 indexed citations
3.
Wang, Huiyu, et al.. (2022). Identification of key sex-specific pathways and genes in the subcutaneous adipose tissue from pigs using WGCNA method. BMC Genomic Data. 23(1). 35–35. 7 indexed citations
4.
Wang, Huiyu, Jie Mei, Xuejing Yang, et al.. (2022). The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma. International Journal of General Medicine. Volume 15. 7383–7393.
5.
Mei, Jie, Yun Cai, Huiyu Wang, et al.. (2022). Formin protein DIAPH1 positively regulates PD-L1 expression and predicts the therapeutic response to anti-PD-1/PD-L1 immunotherapy. Clinical Immunology. 246. 109204–109204. 12 indexed citations
6.
Lü, Jiahui, Jie Mei, Rui Xu, et al.. (2022). NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature. Frontiers in Pharmacology. 13. 1025921–1025921. 1 indexed citations
7.
Mei, Jie, Yun Cai, Rui Xu, et al.. (2021). Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma. Technology in Cancer Research & Treatment. 20. 2203753858–2203753858. 5 indexed citations
8.
Shao, Xinyu, Shishuo Sun, Yuqing Zhou, et al.. (2021). Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis. Cancer Letters. 523. 170–181. 97 indexed citations
9.
Zhou, Weijian, et al.. (2021). Wnt5a: A promising therapeutic target in ovarian cancer. Pathology - Research and Practice. 219. 153348–153348. 8 indexed citations
10.
Shao, Xinyu, et al.. (2021). Combined detection of stool-based methylation indicators for early screening of colorectal neoplasm.. American Journal of Translational Research. 13(10). 11597–11607. 4 indexed citations
11.
Mei, Jie, Dandan Xia, Xuejing Yang, et al.. (2020). BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma. DNA and Cell Biology. 39(10). 1838–1849. 22 indexed citations
12.
Gao, Han, et al.. (2020). The interplay between HIF-1α and noncoding RNAs in cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 27–27. 55 indexed citations
13.
Mei, Jie, et al.. (2020). Evaluation of X‐Ray Repair Cross‐Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma. BioMed Research International. 2020(1). 5751939–5751939. 7 indexed citations
15.
Mei, Jie, Xiaorui Liu, Guangshun Sun, et al.. (2019). Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. Biomarker Research. 7(1). 16–16. 25 indexed citations
16.
Li, Li, Huiyu Wang, Haiping Wang, et al.. (2017). Interaction and oxidative damage of DVDMS to BSA: a study on the mechanism of photodynamic therapy-induced cell death. Scientific Reports. 7(1). 43324–43324. 10 indexed citations
17.
Wang, Xijun, Huiyu Wang, Aihua Zhang, et al.. (2016). Chemical discrimination of cortex Phellodendri amurensis and cortex Phellodendri chinensis by multivariate analysis approach. Pharmacognosy Magazine. 12(45). 41–41. 36 indexed citations
19.
Wang, Huiyu, Guofeng Yue, Chaoqun Dong, et al.. (2014). Carboxybetaine Methacrylate-Modified Nylon Surface for Circulating Tumor Cell Capture. ACS Applied Materials & Interfaces. 6(6). 4550–4559. 36 indexed citations
20.
Dong, Chaoqun, Huiyu Wang, Zhuo Zhang, Tao Zhang, & Baorui Liu. (2014). Carboxybetaine methacrylate oligomer modified nylon for circulating tumor cells capture. Journal of Colloid and Interface Science. 432. 135–143. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026